About ACR Image Metrix

Image Metrix, a division of the American College of Radiology, is on the forefront of applying imaging techniques as a predictive and prognostic biomarker for clinical trials. The key to increasing the efficiency of your drug development program is the integration of the appropriate imaging modality.

Our world-class team of physicians and scientists work with you to integrate the appropriate technology specific to your therapeutic category and compound. We have years expertise and proven expertise in employing state-of-the-art technologies to provide complete imaging services:

• State-of-the-Art Core Laboratories
• Predictive Biomarkers
• CT, MRI/MRS, and PET Image Analysis
• Image Interpretation and Quantitation
• Site Recruitment

With ACR Image Metrix as your imaging partner you have the industry leader in trial design, imaging techniques and image data extraction and analysis. Our world-class team of physicians and scientists has proven experience employing state-of-the-art technologies to provide complete imaging core lab services that will support your goal for: more efficient clinical trials.

Based on your specific compound, ACR Image Metrix provides you with access to subspecialty imaging expertise specific to your clinical trial. Our state-of-the-art imaging core laboratories provide you with access to the latest technologies including CT, MRI/MRS, and PET/nuclear medicine. We developed standard operating process and procedures to ensure the normalization of quantitative data across vendors and platforms.

The effective integration of imaging into clinical trials relies on the ability to support the data acquisition, management, archival and analysis of the data. We established the standard in archiving electronic images and meta-data—our database has over 18 million images available to industry for secondary research and product development.

ACR Image Metrix Video White Papers

The Application Of Novel Imaging Methods To New Drug Development
By Bruce J. Hillman, MD, Chief Scientific Officer, ACR Image Metrix

Dynamic Contrast Enhanced MRI In New Drug Development
By Mark Rosen, MD, PhD, Medical Director, ACR Image Metrix

The Applications Of Positron Emission Tomography (PET) In New Drug Development
By Barry Siegel, MD, Medical Director, ACR Image Metrix

Applying Magnetic Resonance Spectroscopy (MRS) In New Drug Development
By Haresh Poptani, Ph.D., Research Associate Professor of Radiology, University of Pennsylvania